| 1 |
Wang Y, Xue Y, Guo H. Intervention effects of traditional Chinese medicine on stem cell therapy of myocardial infarction. Front Pharmacol 2022;13:1013740. [DOI: 10.3389/fphar.2022.1013740] [Reference Citation Analysis]
|
| 2 |
Leowattana W, Leowattana T, Leowattana P. Human-induced pluripotent stem cell-atrial-specific cardiomyocytes and atrial fibrillation. World J Clin Cases 2022; 10(27): 9588-9601 [DOI: 10.12998/wjcc.v10.i27.9588] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 3 |
Miao W, Shi J, Huang J, Lin Y, Cui C, Zhu Y, Zheng B, Li M, Jiang Q, Chen M. Azoramide ameliorated tachypacing-induced injury of atrial myocytes differentiated from human induced pluripotent stem cell by regulating endoplasmic reticulum stress. Stem Cell Research 2022;60:102686. [DOI: 10.1016/j.scr.2022.102686] [Reference Citation Analysis]
|
| 4 |
Zeng Y, Xiong Y, Yang T, Wang Y, Zeng J, Zhou S, Luo Y, Li L. Icariin and its metabolites as potential protective phytochemicals against cardiovascular disease: From effects to molecular mechanisms. Biomedicine & Pharmacotherapy 2022;147:112642. [DOI: 10.1016/j.biopha.2022.112642] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 5 |
Young JB. Advancement of Technology and Innovation for Future Cardiovascular Care. Advances in Cardiovascular Technology 2022. [DOI: 10.1016/b978-0-12-816861-5.00019-8] [Reference Citation Analysis]
|
| 6 |
Wani S, Dar T, Koli S, Wani WY, Anwar M, Farooq Z. Stem Cell Technology in Medical Biotechnology. Fundamentals and Advances in Medical Biotechnology 2022. [DOI: 10.1007/978-3-030-98554-7_8] [Reference Citation Analysis]
|
| 7 |
Tajabadi M, Goran Orimi H, Ramzgouyan MR, Nemati A, Deravi N, Beheshtizadeh N, Azami M. Regenerative strategies for the consequences of myocardial infarction: Chronological indication and upcoming visions. Biomed Pharmacother 2021;146:112584. [PMID: 34968921 DOI: 10.1016/j.biopha.2021.112584] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 8 |
Stewart CE. Stem cells and regenerative medicine in sport science. Emerg Top Life Sci 2021;5:563-73. [PMID: 34448473 DOI: 10.1042/ETLS20210014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 9 |
Wang X, Liu F, Zhang N, Ma L. Long Non-Coding RNA, Small Nucleolar RNA Host Gene 5, Inhibits the Oxidized Low-Density Lipoprotein Induced Vascular Endothelial Cell Injury by Targeting miR-26a-5p. j biomater tissue eng 2021;11:1961-8. [DOI: 10.1166/jbt.2021.2774] [Reference Citation Analysis]
|
| 10 |
Zhang C, Lin Y, Zhang K, Meng L, Hu X, Chen J, Zhu W, Yu H. GDF11 enhances therapeutic functions of mesenchymal stem cells for angiogenesis. Stem Cell Res Ther 2021;12:456. [PMID: 34384486 DOI: 10.1186/s13287-021-02519-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 11 |
Li N, Guo XY, Zhou J, Yan XL, Yu FF. Atorvastatin Pretreatment Ameliorates Mesenchymal Stem Cell Migration through miR-146a/CXCR4 Signaling. Tissue Eng Regen Med 2021. [PMID: 34260048 DOI: 10.1007/s13770-021-00362-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 12 |
Bian W, Chen W, Nguyen T, Zhou Y, Zhang J. miR-199a Overexpression Enhances the Potency of Human Induced-Pluripotent Stem-Cell-Derived Cardiomyocytes for Myocardial Repair. Front Pharmacol 2021;12:673621. [PMID: 34149424 DOI: 10.3389/fphar.2021.673621] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 13 |
Li H, Niu N, Yang J, Dong F, Zhang T, Li S, Zhao W. Nuclear respiratory factor 1 protects H9C2 cells against hypoxia-induced apoptosis via the death receptor pathway and mitochondrial pathway. Cell Biol Int 2021;45:1784-96. [PMID: 33913583 DOI: 10.1002/cbin.11619] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 14 |
Biagi D, Fantozzi ET, Campos-Oliveira JC, Naghetini MV, Ribeiro AF Jr, Rodrigues S, Ogusuku I, Vanderlinde R, Christie MLA, Mello DB, de Carvalho ACC, Valadares M, Cruvinel E, Dariolli R. In Situ Maturated Early-Stage Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes Improve Cardiac Function by Enhancing Segmental Contraction in Infarcted Rats. J Pers Med 2021;11. [PMID: 34064343 DOI: 10.3390/jpm11050374] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 15 |
Biagi D, Fantozzi ET, Campos-oliveira JC, Naghetini MV, Ribeiro AF, Rodrigues S, Ogusuku I, Vanderlinde R, Christie MLA, Mello DB, de Carvalho ACC, Valadares M, Cruvinel E, Dariolli R. In situ maturated early-stage human induced pluripotent stem cell-derived cardiomyocytes improve cardiac function by enhancing segmentary contraction in infarcted rats.. [DOI: 10.1101/2021.03.09.434658] [Reference Citation Analysis]
|
| 16 |
Hashemzadeh MR, Taghavizadeh Yazdi ME, Amiri MS, Mousavi SH. Stem cell therapy in the heart: Biomaterials as a key route. Tissue Cell 2021;71:101504. [PMID: 33607524 DOI: 10.1016/j.tice.2021.101504] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 10.5] [Reference Citation Analysis]
|
| 17 |
Carresi C, Scicchitano M, Scarano F, Macrì R, Bosco F, Nucera S, Ruga S, Zito MC, Mollace R, Guarnieri L, Coppoletta AR, Gliozzi M, Musolino V, Maiuolo J, Palma E, Mollace V. The Potential Properties of Natural Compounds in Cardiac Stem Cell Activation: Their Role in Myocardial Regeneration. Nutrients 2021;13:275. [PMID: 33477916 DOI: 10.3390/nu13010275] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 18 |
Fakoya AOJ, Fenemigho I, Asuzu CV, Ukponmwan EE, Nnawuba KC, Haider KH. Evolution of Stem Cells in Cardio-Regenerative Therapy. Stem Cells 2021. [DOI: 10.1007/978-3-030-77052-5_7] [Reference Citation Analysis]
|
| 19 |
Zhang X, Li Z, Liu Y, Gai Z. Great Expectations: Induced pluripotent stem cell technologies in neurodevelopmental impairments. Int J Med Sci 2021;18:459-73. [PMID: 33390815 DOI: 10.7150/ijms.51842] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 20 |
Dergilev KV, Shevchenko EK, Tsokolaeva ZI, Beloglazova IB, Zubkova ES, Boldyreva MA, Menshikov MY, Ratner EI, Penkov D, Parfyonova YV. Cell Sheet Comprised of Mesenchymal Stromal Cells Overexpressing Stem Cell Factor Promotes Epicardium Activation and Heart Function Improvement in a Rat Model of Myocardium Infarction. Int J Mol Sci 2020;21:E9603. [PMID: 33339427 DOI: 10.3390/ijms21249603] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 21 |
Yiangou L, Davis RP, Mummery CL. Using Cardiovascular Cells from Human Pluripotent Stem Cells for COVID-19 Research: Why the Heart Fails. Stem Cell Reports. 2021;16:385-397. [PMID: 33306986 DOI: 10.1016/j.stemcr.2020.11.003] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
|
| 22 |
Yuan H, Yang G, Li S, Li L, Wei T, Song G, Luan H, Meng J, Wang Q, Yu Y, Sun J. Calcium sensing receptor involving in therapy of embryonic stem cell transplantation alleviates acute myocardial infarction by inhibiting apoptosis and oxidative stress in rats. Iran J Basic Med Sci 2020;23:1353-9. [PMID: 33149870 DOI: 10.22038/ijbms.2020.47436.10916] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 23 |
Raziyeva K, Smagulova A, Kim Y, Smagul S, Nurkesh A, Saparov A. Preconditioned and Genetically Modified Stem Cells for Myocardial Infarction Treatment. Int J Mol Sci 2020;21:E7301. [PMID: 33023264 DOI: 10.3390/ijms21197301] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 24 |
Désaubry L, Kanthasamy AG, Nebigil CG. Prokineticin signaling in heart-brain developmental axis: Therapeutic options for heart and brain injuries. Pharmacol Res 2020;160:105190. [PMID: 32937177 DOI: 10.1016/j.phrs.2020.105190] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 25 |
Jiang W, Hu X, Li F, Li G, Wang Y. Adrenoceptor Responses in Human Embryonic Stem Cell-Derived Cardiomyocytes: a Special Focus on Electrophysiological Property. J Pharmacol Exp Ther 2020;373:429-37. [PMID: 32217769 DOI: 10.1124/jpet.120.265686] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
